BACKGROUND: Leiomyosarcoma of the inferior vena cava (IVC) is a rare tumor which presents a unique surgical challenge. We present a series of six cases of leiomyosarcoma resection performed with IVC reconstruction. METHODS: Retrospective chart review was performed for patients undergoing initial operative resection of primary leiomyosarcoma with IVC reconstruction, at a tertiary care center. RESULTS: Between 2005-2013, six patients underwent resection with reconstruction. Half were female, and the mean age at presentation was 57 ± 15.4 years. Three patients required en bloc resection with adjacent organs. Three patients were resected on venovenous bypass, and one on cardiopulmonary bypass. Three underwent IVC patch repair (bovine pericardium, n = 2; saphenous vein, n = 1), and three had IVC reconstruction with graft (Dacron, n = 1; PTFE, n = 1; aortic homograft, n = 1). All achieved grossly negative margins. Median disease-free survival was 34 months (IQR 7-52 months), and median disease-specific survival was 51 months (IQR 20-108). Five year disease-free and disease-specific survival rates were 30% and 66.7%, respectively. CONCLUSIONS: Leiomyosarcomas of the IVC present a technical challenge to the surgeon. Careful preoperative workup and a collaborative team consisting of experienced cardiac and vascular surgeons and surgical oncologists can allow for a safe and successful operation despite extensive tumor involvement.
BACKGROUND:Leiomyosarcoma of the inferior vena cava (IVC) is a rare tumor which presents a unique surgical challenge. We present a series of six cases of leiomyosarcoma resection performed with IVC reconstruction. METHODS: Retrospective chart review was performed for patients undergoing initial operative resection of primary leiomyosarcoma with IVC reconstruction, at a tertiary care center. RESULTS: Between 2005-2013, six patients underwent resection with reconstruction. Half were female, and the mean age at presentation was 57 ± 15.4 years. Three patients required en bloc resection with adjacent organs. Three patients were resected on venovenous bypass, and one on cardiopulmonary bypass. Three underwent IVC patch repair (bovine pericardium, n = 2; saphenous vein, n = 1), and three had IVC reconstruction with graft (Dacron, n = 1; PTFE, n = 1; aortic homograft, n = 1). All achieved grossly negative margins. Median disease-free survival was 34 months (IQR 7-52 months), and median disease-specific survival was 51 months (IQR 20-108). Five year disease-free and disease-specific survival rates were 30% and 66.7%, respectively. CONCLUSIONS:Leiomyosarcomas of the IVC present a technical challenge to the surgeon. Careful preoperative workup and a collaborative team consisting of experienced cardiac and vascular surgeons and surgical oncologists can allow for a safe and successful operation despite extensive tumor involvement.
Authors: E Vicente; Y Quijano; H Duran; E Diaz; I Fabra; L Malavé; V Ferri; S Lazzaro; D Kalivaci; R Caruso; Benedetto Ielpo Journal: Surg Endosc Date: 2017-08-04 Impact factor: 4.584
Authors: Christina L Roland; Genevieve M Boland; Elizabeth G Demicco; Kristelle Lusby; Davis Ingram; Caitlin D May; Christine M Kivlin; Kelsey Watson; Ghadah A Al Sannaa; Wei-Lien Wang; Vinod Ravi; Raphael E Pollock; Dina Lev; Janice N Cormier; Kelly K Hunt; Barry W Feig; Alexander J Lazar; Keila E Torres Journal: JAMA Surg Date: 2016-04 Impact factor: 14.766
Authors: Neel A Mansukhani; George E Havelka; Irene B Helenowski; Heron E Rodriguez; Andrew W Hoel; Mark K Eskandari Journal: Surgery Date: 2016-12-20 Impact factor: 3.982
Authors: Maria Baimas-George; Christoph Tschuor; Michael Watson; Jesse Sulzer; Patrick Salibi; David Iannitti; John B Martinie; Erin Baker; Pierre-Alain Clavien; Dionisios Vrochides Journal: Langenbecks Arch Surg Date: 2020-09-26 Impact factor: 3.445
Authors: C Codony; S López-Ben; M Albiol; L Falgueras; E Castro; A Codina-Barreras; M Casellas; J Gil; A Codina-Cazador; J Figueras Journal: Clin Transl Oncol Date: 2016-03-10 Impact factor: 3.405
Authors: Joe L Pantoja; Rhusheet P Patel; Donald T Baril; William Quinones-Baldrich; Peter F Lawrence; Karen Woo Journal: Ann Vasc Surg Date: 2019-11-09 Impact factor: 1.466